Advanced Biomed Inc.

Contributing Author

Recent Articles by Advanced Biomed Inc.

Feb-13	Advanced Biomed Inc. Announces 120-Case Feasibility Study with Chi-Mei Medical Center to Validate A+PerfusC - Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery ADVB GlobeNewswire
Dec-30	Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary ADVB GlobeNewswire
Sep-19	Advanced Biomed Inc. Announces Launch of A+PerfusC - Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery ADVB -17.18% GlobeNewswire